Lincoln Pharmaceuticals Ltd.

LINCOLN

Market Cap
₹1,306 Cr.
P/E
14.00

Lincoln Pharmaceuticals Ltd.

Price
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked
FAQs on Lincoln Pharmaceuticals Ltd. Shareprice

Lincoln Pharma has given lower returns compared to its competitors.
Lincoln Pharma has grown at ~21.12% over the last 6yrs while peers have grown at a median rate of 48.97%

Yes, Lincoln Pharma is expensive.
Latest PE of Lincoln Pharma is 14.0, while 3 year average PE is 10.15.
Also latest EV/EBITDA of Lincoln Pharma is 12.94 while 3yr average is 7.79.

GROWTH TABLE
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
BALANCE SHEET
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
CASH FLOW
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
Quarterly Results
  • Lincoln Pharmaceuticals Ltd.
  • Ind-Swift
  • Bliss GVS Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Filter
markets Market
raw materials Raw Material
FAQs on Lincoln Pharmaceuticals Ltd. Financials

Balance sheet of Lincoln Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Lincoln Pharma is increasing.
Latest debt of Lincoln Pharma is -₹12.76 Crs as of Mar-24.
This is greater than Mar-23 when it was -₹66.27 Crs.

Yes, profit is increasing.
The profit of Lincoln Pharma is ₹93.3 Crs for TTM, ₹72.9 Crs for Mar 2023 and ₹69.36 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lincoln Pharma latest dividend payout ratio is 4.12% and 3yr average dividend payout ratio is 4.43%

Companies resources are majorly tied in miscellaneous assets

Data feed provided by Accord Fintech